ATLAS / Macro Radar / Reporting / ACRS

Aclaris Therapeutics, Inc. (ACRS) reporting calendar

Aclaris Therapeutics, Inc. files periodic reports with the SEC as ACRS on Nasdaq. Atlas tracks 43 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
28 Jul 2026 – 17 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
43

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open ACRS market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001104659-26-057202
10-K31 Dec 202526 Feb 202657 days0001104659-26-020540
10-Q30 Sep 20256 Nov 202537 days0001104659-25-107788
10-Q30 Jun 20257 Aug 202538 days0001558370-25-010789
10-Q31 Mar 20258 May 202538 days0001558370-25-006993
10-K31 Dec 202427 Feb 202558 days0001558370-25-001819
10-Q30 Sep 20246 Nov 202437 days0001558370-24-014646
10-Q30 Jun 20247 Aug 202438 days0001558370-24-011376
10-Q31 Mar 20247 May 202437 days0001558370-24-007069
10-K31 Dec 202327 Feb 202458 days0001558370-24-001753
10-Q30 Sep 20236 Nov 202337 days0001558370-23-017660
10-Q30 Jun 20237 Aug 202338 days0001558370-23-013491
10-Q31 Mar 20238 May 202338 days0001558370-23-008382
10-K31 Dec 202223 Feb 202354 days0001558370-23-001829
10-Q30 Sep 20228 Nov 202239 days0001558370-22-016738
10-Q30 Jun 20223 Aug 202234 days0001558370-22-011757
10-Q31 Mar 202210 May 202240 days0001558370-22-007972
10-K31 Dec 202124 Feb 202255 days0001558370-22-001838
10-Q30 Sep 20212 Nov 202133 days0001558370-21-013989
10-Q30 Jun 20215 Aug 202136 days0001558370-21-010389
10-Q31 Mar 20217 May 202137 days0001558370-21-006362
10-K31 Dec 202025 Feb 202156 days0001558370-21-001717
10-Q30 Sep 20204 Nov 202035 days0001558370-20-012488
10-Q30 Jun 20207 Aug 202038 days0001558370-20-009814
10-Q31 Mar 20207 May 202037 days0001558370-20-005744
10-K31 Dec 201925 Feb 202056 days0001558370-20-001325
10-Q30 Sep 20197 Nov 201938 days0001558370-19-010425
10-Q30 Jun 20198 Aug 201939 days0001558370-19-007745
10-Q31 Mar 20198 May 201938 days0001558370-19-004494
10-K31 Dec 201818 Mar 201977 days0001558370-19-002211
10-Q30 Sep 20186 Nov 201837 days0001558370-18-008658
10-Q30 Jun 20183 Aug 201834 days0001558370-18-006295
10-Q31 Mar 20188 May 201838 days0001558370-18-004349
10-K31 Dec 201712 Mar 201871 days0001558370-18-001866
10-Q30 Sep 20177 Nov 201738 days0001558370-17-008320
10-Q30 Jun 20178 Aug 201739 days0001558370-17-006211
10-Q31 Mar 20179 May 201739 days0001558370-17-004000
10-K31 Dec 201615 Mar 201774 days0001558370-17-001802
10-Q30 Sep 20163 Nov 201634 days0001558370-16-009151
10-Q30 Jun 201611 Aug 201642 days0001558370-16-007893

Source: SEC EDGAR company submissions for CIK 0001557746. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.